Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6282270 | 0.82 | TDP1 (0.43) | KDM4EMAPTMAPK1MEN1LMNA | |
| SCHEMBL6286875 | 0.80 | KDM4E (0.38) | KDM4EMAPTMAPK1MEN1LMNA | |
| SCHEMBL6290916 | 0.79 | KDM4E (0.36) | KDM4EMAPTMAPK1MEN1LMNA | |
| SCHEMBL6287377 | 0.78 | KDM4E (0.37) | KDM4EMAPTMAPK1MEN1LMNA | |
| SCHEMBL6284037 | 0.78 | ALDH1A1 (0.40) | KDM4EMAPTMAPK1MEN1LMNA | |
| SCHEMBL6290821 | 0.76 | KDM4E (0.35) | KDM4EMAPTMAPK1MEN1LMNA | |
| SCHEMBL10254545 | 0.76 | MAPT (0.47) | KDM4EMAPTMAPK1MEN1LMNA | |
| SCHEMBL864426 | 0.76 | MAPT (0.47) | KDM4EMAPTMAPK1MEN1LMNA | |
| SCHEMBL6287761 | 0.76 | KDM4E (0.44) | KDM4EMAPTMAPK1MEN1LMNA | |
| SCHEMBL9651830 | 0.71 | MAPT (0.50) | KDM4EMAPTMAPK1MEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040088798-A1 | Oxidation dyeing composition for keratinous fibres and dyeing method using same | LANG GERARD (FR) | 2004-05-13 | — | — | US | claimed |
| US-20030167579-A1 | Oxidation dyeing composition for keratinous fibres and dyeing method using same | L'OREAL S.A. (FR) | 2003-09-11 | — | — | US | claimed |
| US-20030159221-A1 | Oxidation dyeing composition for keratinous fibres with a particular paraphenylene-diamine derivative and a particular direct dyeing agent | L'OREAL S.A. (FR) | 2003-08-28 | — | — | US | claimed |
| US-20030028977-A1 | Oxidation dyeing composition for keratinous fibres and dyeing method using same | L'OREAL S.A. (FR) | 2003-02-13 | — | — | US | claimed |
| US-20030009835-A1 | Oxidation dyeing composition for keratinous fibres and dyeing method using same | L'OREAL S.A. (FR) | 2003-01-16 | — | — | US | claimed |
| US-6890362-B2 | Oxidation dyeing composition for keratinous fibers and dyeing method using same | L'OREAL, S.A. (FR) | 2005-05-10 | — | — | US | disclosed |
| US-20040088798-A1 | Oxidation dyeing composition for keratinous fibres and dyeing method using same | LANG GERARD (FR) | 2004-05-13 | — | — | US | disclosed |
| US-20030167579-A1 | Oxidation dyeing composition for keratinous fibres and dyeing method using same | L'OREAL S.A. (FR) | 2003-09-11 | — | — | US | disclosed |
| US-20030159221-A1 | Oxidation dyeing composition for keratinous fibres with a particular paraphenylene-diamine derivative and a particular direct dyeing agent | L'OREAL S.A. (FR) | 2003-08-28 | — | — | US | disclosed |
| US-20030028977-A1 | Oxidation dyeing composition for keratinous fibres and dyeing method using same | L'OREAL S.A. (FR) | 2003-02-13 | — | — | US | disclosed |
| US-20030009835-A1 | Oxidation dyeing composition for keratinous fibres and dyeing method using same | L'OREAL S.A. (FR) | 2003-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030159221-A1 | Oxidation dyeing composition for keratinous fibres with a particular paraphenylene-diamine derivative and a particular direct dyeing agent | KRT18, CDC73, DAO | KDM4E 1731/4885MAPT 1020/4885MAPK1 1723/4885 |
| US-20030028977-A1 | Oxidation dyeing composition for keratinous fibres and dyeing method using same | KRT18, NDUFB5, NDUFB4 | KDM4E 1488/4885MAPT 805/4885MAPK1 1163/4885 |
| US-20030167579-A1 | Oxidation dyeing composition for keratinous fibres and dyeing method using same | KRT18, PPOX, COXFA4L2 | KDM4E 2464/4885MAPT 878/4885MAPK1 1544/4885 |
| US-20040088798-A1 | Oxidation dyeing composition for keratinous fibres and dyeing method using same | KRT18, OAT, ACOX1 | KDM4E 1809/4885MAPT 1555/4885MAPK1 2549/4885 |
| US-20030009835-A1 | Oxidation dyeing composition for keratinous fibres and dyeing method using same | KRT18, PPOX, NDUFB5 | KDM4E 2568/4885MAPT 540/4885MAPK1 1409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.